GSK Has One Week To Hand Over Zofran Data, Judge Says
By Chris Villani (March 27, 2018, 12:20 PM EDT) -- A Massachusetts federal judge late Monday gave GlaxoSmithKline one week to provide families who blame its popular anti-nausea drug Zofran for causing birth defects a list of all available information involving adverse effects caused by the drug.
In a two-page order issued just hours after oral arguments were held in Boston over the disclosure dispute, U.S. Magistrate Judge Judith Dein ordered GSK to turn over a list of the available fields that can be exported from its database on adverse effects, called Argus. The families have argued Argus data is easily searchable and sortable, and includes information GSK did not reveal...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!